UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016826
Receipt number R000019528
Scientific Title The evaluation of oxidative stress and the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.
Date of disclosure of the study information 2015/03/31
Last modified on 2020/04/23 23:33:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The evaluation of oxidative stress and the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.

Acronym

The evaluation of oxidative stress and the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.

Scientific Title

The evaluation of oxidative stress and the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.

Scientific Title:Acronym

The evaluation of oxidative stress and the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.

Region

Japan


Condition

Condition

Idiopathic pulmonary fibrosis (IPF)

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the association between oxidative stress and disease severity in patients with IPF. And, to evaluate the effects of pirfenidone on oxidative stress in patients with IPF.

Basic objectives2

Others

Basic objectives -Others

To establish the new markers for disease progression.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Oxidative stress markers

Key secondary outcomes

Pulmonary function test, 6-minute walking test, St. George's Respiratory Questionnaire, Inflammatory cytokine, Incidence rate of acute exacerbation, Exacerbation-free survival time


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Pirfenidone

Interventions/Control_2

Observation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are diagnosed as IPF, as defined by the 2011 ATS/ERS/JRS/ALAT statement.

Key exclusion criteria

1. The patients who disagree with involving in this study.
2. The patients had taken oral steroid medication and immunosuppressive therapy.
3. The patients who diagnosed as respiratory disorders other than IPF, malignancy, overt cardiac failure, and hepatic and renal disease.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name SHUJI
Middle name
Last name OH-ISHI

Organization

National Hospital Organization Ibarakihigashi National Hospital

Division name

Department of Respiratory Medicine

Zip code

319-1113

Address

825 Terunuma, Tokai-mura, Naka-gun, Ibaraki 319-1113, Japan

TEL

+81-29-282-1151

Email

ooishi.shuji.dg@mail.hosp.go.jp


Public contact

Name of contact person

1st name SHUJI
Middle name
Last name OH-ISHI

Organization

National Hospital Organization Ibarakihigashi National Hospital

Division name

Department of Respiratory Medicine

Zip code

319-1113

Address

825 Terunuma, Tokai-mura, Naka-gun, Ibaraki 319-1113, Japan

TEL

+81-29-282-1151

Homepage URL


Email

ooishi.shuji.dg@mail.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Ibarakihigashi National Hospital

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Ibarakihigashi National Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ibarakihigashi National Hospial

Address

825 Terunuma, Tokai-mura, Naka-gun, Ibaraki 319-1113, Japan

Tel

+81-29-282-1151

Email

yamano.yoichi.pn@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構茨城東病院(茨城県)


Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results

Because we won't be able to collect the number of participants enough to analyze the data of the primary endpoint, we couldn't help but terminate this study.

Results date posted

2020 Year 04 Month 23 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 01 Month 15 Day

Date of IRB

2015 Year 01 Month 29 Day

Anticipated trial start date

2015 Year 03 Month 31 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 03 Month 17 Day

Last modified on

2020 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019528


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name